Biomedical Engineering Core
- Institution
- Icahn School of Medicine at Mount Sinai, NY
- Principal investigator
- Abraham Teunissen
- Funding
- $35K
- Duration
- 2017–2028
Moonbase score
Still being scored
Abstract
SUMMARY FOR CORE C The Biomedical Engineering Core C will support this program project's nanotherapeutic studies. The Core will operate from Mount Sinai under the direction of Dr. Abraham Teunissen, an expert in nanotechnology and organic chemistry. Dr. Teunissen also has extensive expertise in leading teams of scientists through his roles as Director of Mount Sinai’s Radiochemistry Facility and co-Director of our Nanomedicine lab. The Core will provide trained immunity-inhibiting nanobiologics for modulating stress-induced immune reprogramming in Projects 2 and 3. The Core will provide these nanotherapeutics on demand and arrange their transport to all collaborators. Moreover, Dr. Teunissen’s expertise enables this Core to efficiently respond to newly discovered therapeutic targets by developing novel nanoformulations.
LOADING MOONBASE SCORE
Questions for Icahn School of Medicine at Mount Sinai
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Icahn School of Medicine at Mount SinaiNot yet scored
Studying and regulating trained immunity in mouse transplant models
Abraham Teunissen · $920K · 2023–2028
- NIH · Icahn School of Medicine at Mount Sinai58
Potentiating Checkpoint Blockade by Cross-Priming Tumor-Reactive T cells with In Situ Vaccination
Joshua D Brody · $352K · 2024–2026
- NIH · Icahn School of Medicine at Mount Sinai58
Defining and targeting the lung cancer progenitor cell niche using a high-resolution, multi-omics approach
Daniel Charytonowicz · $55K · 2021–2026